Last Update Time:
19-Mar-2025 16:00:00
ISIN:
INE398R01022
Sector:
Healthcare
Symbol:
SYNGENE
Syngene International Limited
₹705.55
₹22.75
(3.33%)
▲
Prev. Close
₹682.80
Open
₹685.00
Close
₹706.05
Range
₹670.27 - ₹740.83
High
₹708.90
Low
₹684.95
Ind. Close
₹0.00
VWAP
₹699.14
The current stock price of Syngene International Limited is ₹705.55, with a target price range between ₹670.27 and ₹740.83. The stock has experienced a price change of ₹22.75 (3.33%), reflecting recent market volatility.
Today's opening price was ₹685.00, while the previous close stood at ₹682.80.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Syngene International Limited Price Chart
Syngene International Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 685
- Previous Close Price: 682.8
- Change: 2.20%
- Total Traded Volume: 305
- Total Buy Quantity: 3,821
- Total Sell Quantity: 2,097
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 675.00 | 152.00 | 0.00 |
| 676.00 | 2.00 | 0.00 |
| 680.00 | 2.00 | 0.00 |
| 682.80 | 108.00 | 0.00 |
| 683.35 | 37.00 | 0.00 |
| 685.00 | 0.00 | 58.00 |
| 685.50 | 0.00 | 33.00 |
| 685.90 | 0.00 | 33.00 |
| 686.00 | 0.00 | 2.00 |
| 686.10 | 0.00 | 33.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 3821
Total Sell Quantity: 2097
Shareholding Patterns of Syngene International Limited
Key Trade Statistics of Syngene International Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 5.84 |
| Traded Value (₹ Cr.) | 40.80 |
| Total Market Cap (₹ Cr.) | 28,401.00 |
| Free Float Market Cap (₹ Cr.) | 12,723.33 |
| Impact cost | 0.05 |
| Quantity Traded | 583,638.00 |
| Deliverable Quantity | 304,063.00 |
| % of Quantity to Traded | 52.1 |
| Security VaR | 10.58 |
| Index VaR | N/A |
| VaR Margin | 10.58 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 14.08 |
| Face Value | 10 |
Key Price Statistics of Syngene International Limited
The 52-week high for Syngene International Limited was ₹960.60, recorded on 02-Dec-2024. On the other hand, the 52-week low stands at ₹607.65, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹751.05, and the lower band is ₹614.55. The price band is No Band%.
The stock's daily volatility stands at 1.68, while the annualized volatility is 32.10. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (02-Dec-2024) | 960.60 |
| 52 Week Low (04-Jun-2024) | 607.65 |
| Upper Band | 751.05 |
| Lower Band | 614.55 |
| Price Band (%) | No Band |
| Daily Volatility | 1.68 |
| Annualised Volatility | 32.10 |
| Tick Size | 0.05 |
Key Securities Statistics of Syngene International Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 11-Aug-2015 |
| Adjusted P/E | 57.79 |
| Symbol P/E | 54.81 |
| Index | NIFTY 500 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Healthcare Research Analytics & Technology |
Security Status of Syngene International Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Syngene International Limited
| Subject | Date |
|---|---|
| Press Release | 19-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 19-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 18-Mar-2025 |
| Reply to Clarification- Financial results | 17-Mar-2025 |
| Investor Presentation | 12-Mar-2025 |
| Acquisition-XBRL | 10-Mar-2025 |
| Acquisition | 10-Mar-2025 |
| Press Release | 10-Mar-2025 |
Corporate Actions of Syngene International Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Dividend - Rs 1.25 Per Share | 28-Jun-2024 |
| 10 | Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share | 30-Jun-2023 |
| 10 | Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share | 30-Jun-2022 |
| 10 | Annual General Meeting | 13-Jul-2021 |
| 10 | Dividend - Rs 0.50 Per Share | 16-Jul-2019 |
| 10 | Bonus 1:1 | 11-Jun-2019 |
| 10 | Dividend Re - Re 1 Per Share | 17-Jul-2018 |
| 10 | Dividend - Rs 1/- Per Share | 20-Jul-2017 |
| 10 | Interim Dividend - Re 1/- Per Share (Purpose Revised) | 17-Mar-2016 |
Board Meetings of Syngene International Limited
Financial Results of Syngene International Limited
Company Directory of Syngene International Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.syngeneintl.com | Registered Office | Biocon Park, SEZ Bommasandra Industrial Area, Jigani Link Road, Bommasandra, Bangalore | BANGALORE |
| www.syngeneintl.com | Transfer Agent | Karvy Computershare Private Limited Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda | HYDERABAD |
Insider Trading of Syngene International Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | ANJAN CHAKRABARTI | 5265152 | Sell |
| 7(2) | ANJAN CHAKRABARTI | 50199635 | Buy |
| 7(2) | ANJAN CHAKRABARTI | 22944288 | Sell |
| 7(2) | Biocon Limited | 6861440000 | Sell |
| 7(2) | DEEPAK VENKATRAMAN | 533610 | Sell |
| 7(2) | DEEPAK VENKATRAMAN | 544290 | Sell |
| 7(2) | Mayank Verma | 1369755 | Sell |
| 7(2) | ALOK MEHROTRA | 17520600 | Buy |
| 7(2) | ALOK MEHROTRA | 7037404 | Sell |
| 7(2) | SIBAJI BISWAS | 76917540 | Buy |
| 7(2) | SIBAJI BISWAS | 31977400 | Sell |
| 7(2) | CHETAN PRAKASH TAMHANKA | 2091398 | Sell |
| 7(2) | Ajit Manocha | 2276560 | Sell |
| 7(2) | Ajit Manocha | 2180000 | Sell |
| 7(2) | Ajit Manocha | 4225000 | Sell |
| 7(2) | ALOK MEHROTRA | 853990 | Sell |
| 7(2) | ALOK MEHROTRA | 428540 | Sell |
| 7(2) | Manoj Gupta | 5443200 | Sell |
| 7(2) | G KRISHNAN | 4234400 | Sell |
| 7(2) | CHETAN PRAKASH TAMHANKA | 5971029 | Sell |
Annual Reports of Syngene International Limited
Investor Complaints of Syngene International Limited
Event Calendar of Syngene International Limited
| Purpose | Details |
|---|---|
| Results | inter alia, to approve and take on record the un-audited financial results for the quarter ended on September 30, 2015. |
| Results | to approve and take on record the un-audited financial results for the quarter ended on December 31, 2015. |
| Dividend | To consider and declare Interim Dividend on the paid up equity share capital of the Company via circular resolution for the financial year 2015-16. |
| Results | inter alia, to approve and take on record the audited financial results for the financial year ended on March 31, 2016. |
| Results | Inter alia, to approve and take on record the un-audited financial results for the quarter ended on June 30, 2016. |
| Results | inter alia, to approve and take on record the un-audited financial results for the quarter and half year ended on September 30, 2016. |
| Results | Inter alia, to approve and take on record the un-audited financial results for the quarter ended on December 31, 2016. |
| Results | to approve and take on record the audited financial results for the financial year ended on March 31, 2017. |
| Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held April 27, 2017, to approve and take on record the audited financial results for the financial year ended on March 31, 2017. The Company has now informed the Exchange that at the meeting of the Board of Directors, proposal for consideration and recommendation of final dividend, if any, shall also be considered for the financial year ended March 31, 2017.(purpose revised) |
| Results | Inter alia, to approve and take on record the un-audited financial results for the quarter ended June 30, 2017. |
| Results | SYNGENE : 25-Oct-2017 : Inter alia, to approve and take on record the un-audited financial results for the quarter and half year ended September 30, 2017. |
| Results | Inter alia, to approve and take on record the un-audited financial results for the quarter and half year ended September 30, 2017. |
| Results | inter alia, to approve and take on record the un-audited financial results for the quarter ended December 31, 2017. |
| Financial Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on April 25, 2018To consider and approve the financial results for the period ended March 31, 2018 . The Company has now informed the Exchange that the Board of Director also considered and recommendation of final dividend, if any for the financial year ended March 31, 2018.(Purpose Revised). |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2018 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2018 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | inter-alia, to consider and approve the financial results for the period ended March 31, 2019 and payment of dividend, if any |
| Bonus | To consider a proposal for issue of bonus shares |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | Inter alia to consider and approve the Un-audited Standalone and Consolidated financial results for the quarter and half year ended on September 30, 2019. |
| Financial Results | Inter-alia, to consider and approve the financial results for the quarter and nine months ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the unaudited financial results for the period ended Jun 30, 2020 |
| Financial Results | Board Meeting to be held on October 21, 2020, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Dividend | To consider dividend |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Syngene International Limited has informed the Exchange about Board Meeting to be held on 20-Jul-2022 to consider financial statements for the period ended June 2022. |
| Financial results | Syngene International Limited has informed the Exchange about Board Meeting to be held on 19-Oct-2022, inter alia, to consider and approve financial statements for the period ended September 2022. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2023 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024, and dividend, if any. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Syngene International Limited
Voting Results of Syngene International Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 24-JUL-2024 | AGM | Adoption of Audited Financial Statements: a) To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2024, and the reports of the Board of Directors and Auditors thereon. b) To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, and the report of the Auditors thereon. |
| 24-JUL-2024 | AGM | To approve the appointment of Ms. Manja Boerman (DIN: 10655368) as an Independent Director of the Company. |
| 24-JUL-2024 | AGM | To approve the re-appointment of Dr. Kush Parmar (DIN: 09212020) as an Independent Director of the Company. |
| 24-JUL-2024 | AGM | To approve the appointment of Ms. Kiran Mazumdar Shaw (DIN: 00347229) as director liable to retire by rotation. |
| 24-JUL-2024 | AGM | Declaration of Dividend: To declare a final dividend of Rs. 1.25 per equity share for the financial year ended March 31, 2024. |
| 10-JUN-2024 | Postal Ballot | To approve the re-appointment of Mr. Jonathan Brittan Hunt (DIN:07774619) as Managing Director and Chief Executive Officer of the Company |
| 10-JUN-2024 | Postal Ballot | To approve the appointment of Mr. Nilanjan Roy (DIN: 02703775) as an Independent Director of the Company |
| 10-JUN-2024 | Postal Ballot | To approve the appointment of Mr. Sibaji Biswas (DIN: 06959449) as Executive Director & Chief Financial Officer of the Company |
| 26-JUL-2023 | AGM | Adoption of Audited Financial Statements: a) To consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, and the reports of the Board of Directors and Auditors thereon. b) To consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2023, and the report of the Auditors thereon. |
| 26-JUL-2023 | AGM | To approve the appointment of Ms. Catherine Rosenberg (DIN: 06422834) as Director liable to retire by rotation |
| 26-JUL-2023 | AGM | Declaration of Dividend: To declare a final dividend of Rs. 1.25/- per equity share (Re. 0.50 regular dividend and Re. 0.75 as an additional special dividend to mark the 30th anniversary of the founding of the Company in November 1993) for the Financial Year ended March 31, 2023. |
| 23-APR-2023 | Postal Ballot | To approve the Syngene Long Term Incentive Performance Share Plan 2023 and grant of Performance Share Units (PSUs) to eligible employees of the Company. |
| 23-APR-2023 | Postal Ballot | To approve the termination of Syngene Employee Stock Option Plan 2011 (￢ﾀﾜthe ESOP Plan￢ﾀﾝ). |
| 23-APR-2023 | Postal Ballot | To approve the provision of money by the Company for the purchase of its own shares by the Syngene Employees Welfare Trust for the benefit of employees under Syngene Long Term Incentive Performance Share Plan 2023 and Syngene Long Term Incentive Outperformance Share Plan 2023. |
| 23-APR-2023 | Postal Ballot | To approve extending the benefits of the Syngene Long Term Incentive Outperformance Share Plan 2023 to the employees of Holding Company, subsidiary(ies) including future subsidiary(ies). |
| 23-APR-2023 | Postal Ballot | To approve extending the benefits of the Syngene Long Term Incentive Performance Share Plan 2023 to the employees of Holding Company, subsidiary(ies) including future subsidiary(ies). |
| 23-APR-2023 | Postal Ballot | To approve the Syngene Long Term Incentive Outperformance Share Plan 2023 and grant of Performance Share Units (PSUs) to eligible employees of the Company. |
| 20-JUL-2022 | AGM | To consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2022, together with the Reports of the Board of Directors and the Auditors thereon. |
| 20-JUL-2022 | AGM | To appoint a Director in place of Kiran Mazumdar Shaw (DIN: 00347229), Non-Executive Chairperson, who retires by rotation and being eligible, offers herself fornre-appointment. |
| 20-JUL-2022 | AGM | To declare a final dividend of Re. 1.00 per equity share (Re.0.50 regular dividend and Re. 0.50 additional special dividend) for the Financial Year ended March 31, 2022. |
FAQs on Syngene International Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.